Previous 10 | Next 10 |
Alkermes to Present Data on Nemvaleukin Alfa at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium PR Newswire DUBLIN , Jan. 18, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced plans to present a poster related to ne...
--News Direct-- DUBLIN, January 14, 2022 /3BL Media/ - Results from a newly released survey provide insights from adults living with bipolar I disorder (BD-I)* in the United States (U.S.) on the burden of living with this serious mental health condition and their experiences with treatm...
--News Direct-- Alkermes is committed to researching and developing potential new cancer treatment options that may help address unmet patient needs. Clinical trials are an important step in evaluating the safety and efficacy of potential treatments. Learn more about the ongoing cl...
New National Survey of People Living with Bipolar I Disorder Provides Insights Into Disease-Related Challenges and the Treatment Journey - Respondents Reported Physical and Psychosocial Impacts of Living with Bipolar I Disorder and Side Effects of Medications Used to Treat the D...
Alkermes to Take Part in the 40th Annual J.P. Morgan Healthcare Conference PR Newswire DUBLIN , Jan. 5, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops , will provide a corporate overview...
--News Direct-- Our culture is rooted in respect for all and an unwavering commitment to, and passion for, our work. Learn more about what makes Alkermes’ culture unique: https://bit.ly/3lHO4n8 About Alkermes Alkermes plc is a fully-integrated, global biopharmace...
--News Direct-- While coping with the effects of cancer during the holidays is difficult, we find hope in the research work being done at Alkermes to help expand the future of cancer treatment for patients and their families. About Alkermes Alkermes plc is a fully...
--News Direct-- In the words of our CEO Richard Pops, diversity, inclusion & belonging are “integral to our company’s culture and success.” In 2020, we launched Employee Resource Groups with a common purpose of supporting and enhancing the inclusiveness of our c...
--News Direct-- On the heels of COP26 , we’re reminded of our collective responsibility to respond effectively to the climate crisis . In 2020, we opened a new energy-efficient office and lab facility in MA and continued to make strides aimed at reducing our environme...
--News Direct-- This #GivingTuesday we recognize the many employees who take time to support members of our communities who are in need. More than 10 years ago, we launched Alkermes in Action, an annual employee volunteer program designed to support volunteer efforts within our local co...
News, Short Squeeze, Breakout and More Instantly...
Alkermes to Report Second Quarter Financial Results on July 24, 2024 PR Newswire DUBLIN , July 17, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET ( 1:00 p.m. BST ) on Wednesday, ...
2024-06-29 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-19 17:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...